<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: <z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi> E (apoE) has been implicated in regenerative processes in the brain after trauma, as well as in the pathogenesis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000005'>Inheritance</z:hpo> of a specific apo epsilon allele (apo epsilon 4) determines in part the risk and the mean age at <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>ApoE has been found to bind isoform specifically to beta-amyloid protein, the major component of <z:hpo ids='HP_0100256'>senile plaques</z:hpo>, and to the microtubule associated protein tau, which forms <z:hpo ids='HP_0002185'>paired helical filaments</z:hpo> and <z:hpo ids='HP_0002185'>neurofibrillary tangles</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim was to further examine the relation between apo epsilon alleles, especially apo epsilon 4, and the development of neuropathological changes associated with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Brains of patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (n = 44) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (n = 11) and of age matched controls (n = 29) were studied </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0100256'>Senile plaques</z:hpo> and <z:hpo ids='HP_0002185'>neurofibrillary tangles</z:hpo> in the hippocampus and frontal cortex were quantified </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: No correlation was found between the number of apo epsilon 4 alleles and the number of <z:hpo ids='HP_0100256'>senile plaques</z:hpo> and <z:hpo ids='HP_0002185'>neurofibrillary tangles</z:hpo> in the hippocampus or the frontal cortex of patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, or vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, or control groups </plain></SENT>
<SENT sid="7" pm="."><plain>No significant differences in duration or severity of <z:hpo ids='HP_0000726'>dementia</z:hpo> were found between patients with or. without the apo epsilon 4 allele </plain></SENT>
<SENT sid="8" pm="."><plain>No increased frequency of apo epsilon 4 was found in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION AND COMMENT: Although the apo epsilon genotype clearly affects whether <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> will develop or not, the present study suggests that it has no influence on pathology or clinical intellectual status, once the <z:hpo ids='HP_0000726'>dementia</z:hpo> has manifested itself </plain></SENT>
<SENT sid="10" pm="."><plain>No increased apo epsilon 4 allele frequency was found in neuropathologically diagnosed patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> in whom concomitant <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> can be excluded </plain></SENT>
</text></document>